blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3615514

EP3615514 - PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  20.10.2023
Database last updated on 05.08.2024
FormerGrant of patent is intended
Status updated on  31.05.2023
FormerExamination is in progress
Status updated on  17.09.2021
FormerRequest for examination was made
Status updated on  31.01.2020
FormerThe international publication has been made
Status updated on  03.11.2018
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): IT, SK
published on 04.09.2024 [2024/36]
Applicant(s)For all designated states
Aviara Pharmaceuticals, Inc.
3331 Green Tree Park
Houston, TX 77007-8371 / US
[2020/10]
Inventor(s)01 / BIEDIGER, Ronald, J.
5311 Golden Wings Ct.
Houston, TX 77041 / US
02 / BENISH, Michele, A.
6 Barlow Ct.
The Woodlands, TX 77382 / US
03 / HARDY, Lindsay, Bonner
37 Winthrop Rd.
Lexington, MA 02421 / US
04 / BOYD, Vincent, A.
13135 FM 850
Tyler, TX 75707 / US
05 / MARKET, Robert, V.
11408 Rashell Way
Pearland, TX 77584 / US
06 / THRASH, Thomas, P.
4430 Wigton Dr.
Houston, TX 77096 / US
07 / YOUNG, Brandon, M.
8132 Effingham Dr.
Germantown, TN 38138 / US
 [2020/10]
Representative(s)Beck Greener LLP
Fulwood House
12 Fulwood Place
London WC1V 6HR / GB
[2020/10]
Application number, filing date18791126.825.06.2018
[2020/10]
WO2018US39289
Priority number, dateUS20171549741426.04.2017         Original published format: US201715497414
[2020/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2018201167
Date:01.11.2018
Language:EN
[2018/44]
Type: A2 Application without search report 
No.:EP3615514
Date:04.03.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 01.11.2018 takes the place of the publication of the European patent application.
[2020/10]
Type: B1 Patent specification 
No.:EP3615514
Date:22.11.2023
Language:EN
[2023/47]
Search report(s)International search report - published on:RU20.12.2018
(Supplementary) European search report - dispatched on:EP27.08.2020
ClassificationIPC:C07D213/75, C07D221/04, C07D237/22, C07D401/12, C07D405/12, C07D409/12, C07D409/14, C07D413/12, C07D413/14, C07D417/12, C07D471/00, C07D471/04, C07D495/04, A61K31/435, A61K31/4353, A61K31/4375, A61K31/4412, A61K31/443, A61K31/4436, A61K31/4439, A61P35/00
[2020/40]
CPC:
C07D213/75 (EP,US); C07D498/04 (US); A61P35/00 (EP,US);
C07D207/327 (EP,US); C07D207/333 (EP,US); C07D209/08 (EP,US);
C07D213/48 (EP,US); C07D213/55 (EP,US); C07D213/64 (EP,US);
C07D213/69 (EP,US); C07D221/04 (EP,US); C07D221/18 (US);
C07D231/16 (EP,US); C07D237/14 (US); C07D237/22 (EP,US);
C07D261/08 (EP,US); C07D307/54 (EP,US); C07D333/22 (EP,US);
C07D401/12 (EP,US); C07D471/04 (EP,US); C07D513/04 (EP,US) (-)
Former IPC [2020/10]C07D213/75, C07D221/04, C07D237/22, C07D401/12, C07D405/12, C07D409/12, C07D409/14, C07D413/12, C07D413/14, C07D417/12, C07D471/00, C07D471/04, C07D495/04, A61K31/435, A61K31/4353, A61K31/4375, A61K31/4412, A61K31/443, A61K31/4436, A61K31/4439
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/10]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:PROPIONSÄUREDERIVATE UND VERFAHREN ZUR VERWENDUNG DAVON[2020/10]
English:PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF[2020/10]
French:DÉRIVÉS D'ACIDE PROPIONIQUE ET LEURS PROCÉDÉS D'UTILISATION[2020/10]
Entry into regional phase26.11.2019National basic fee paid 
26.11.2019Search fee paid 
26.11.2019Designation fee(s) paid 
26.11.2019Examination fee paid 
Examination procedure25.06.2018Loss of particular rights, legal effect: Priority
26.11.2019Examination requested  [2020/10]
15.01.2020Despatch of communication of loss of particular rights: Priority 0001
30.06.2021Amendment by applicant (claims and/or description)
17.09.2021Despatch of a communication from the examining division (Time limit: M06)
21.04.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
29.06.2022Reply to a communication from the examining division
05.10.2022Despatch of a communication from the examining division (Time limit: M04)
06.02.2023Reply to a communication from the examining division
01.06.2023Communication of intention to grant the patent
04.10.2023Fee for grant paid
04.10.2023Fee for publishing/printing paid
04.10.2023Receipt of the translation of the claim(s)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
29.06.2022Request for further processing filed
29.06.2022Full payment received (date of receipt of payment)
Request granted
08.07.2022Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
30.06.2021Request for further processing filed
30.06.2021Full payment received (date of receipt of payment)
Request granted
12.07.2021Decision despatched
Fees paidRenewal fee
25.06.2020Renewal fee patent year 03
23.06.2021Renewal fee patent year 04
20.06.2022Renewal fee patent year 05
27.06.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.11.2023
CZ22.11.2023
EE22.11.2023
ES22.11.2023
HR22.11.2023
IT22.11.2023
LT22.11.2023
LV22.11.2023
NL22.11.2023
PL22.11.2023
RO22.11.2023
RS22.11.2023
SK22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
[2024/36]
Former [2024/35]AT22.11.2023
CZ22.11.2023
EE22.11.2023
ES22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
NL22.11.2023
PL22.11.2023
RO22.11.2023
RS22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/34]AT22.11.2023
EE22.11.2023
ES22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
NL22.11.2023
PL22.11.2023
RS22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/33]AT22.11.2023
ES22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
NL22.11.2023
PL22.11.2023
RS22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/26]AT22.11.2023
ES22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
NL22.11.2023
PL22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/25]AT22.11.2023
ES22.11.2023
HR22.11.2023
LT22.11.2023
NL22.11.2023
PL22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/24]AT22.11.2023
ES22.11.2023
HR22.11.2023
LT22.11.2023
NL22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/23]AT22.11.2023
ES22.11.2023
LT22.11.2023
NL22.11.2023
BG22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/21]LT22.11.2023
NL22.11.2023
BG22.02.2024
GR23.02.2024
IS22.03.2024
Former [2024/20]GR23.02.2024
IS22.03.2024
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[X]WO0067746  (TEXAS BIOTECHNOLOGY CORP [US], et al) [X] 1-22 * , claims 1-10, 13-15, abstract *;
 [A]WO0068188  (TEXAS BIOTECHNOLOGY CORP [US], et al) [A] 1-22 * , claims, abstract *;
 [A]US6262084  (BIEDIGER RONALD J [US], et al) [A] 1-22* , claims, abstract *;
 [X]EP1203766  (TEXAS BIOTECHNOLOGY CORP [US]) [X] 1-22 * , claims 1-19, 30, 31, paragraphs [0073], [0074], [0151], abstract *
by applicantUS781203
 EP0341915
 EP0422938
 US5192746
 WO9515973
 WO9606108
 US5510332
 WO9622966
 WO9804247
 WO9804913
 US6262084
 US6723711
 US2004234624
 WO2005014534
 US6972296
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.